[Histonet] Invitation from Dr. Helen Moore, OBBR, NCI to attendFree BRN Sypmposium in March

From:"Dr. Andrea Kelly"



The National Cancer Institute (NCI) Office of Biorepositories and=20
Biospecimen Research (OBBR) and the National Institutes of Health Office 
of Rare Diseases announce the Biospecimen Research Network (BRN) Symposium:

 

*"/Advancing Cancer Research Through Biospecimen Science"/*

*March 13-14, 2008*

Renaissance M Street Hotel

1143 New Hampshire Avenue NW

Washington, D.C.

 

The primary goal of the symposium is to address the significant impact 
of pre-analytical biospecimen variability on cancer research and 
molecular medicine.

 

The symposium will feature expert presentations and interactive 
discussions on topics in biospecimen science including:

         /HER2/neu/: Lessons Learned

         Access to Existing Knowledge in Biospecimen Science

         Research Advances in Biospecimen Science

         Assessing and Qualifying Biospecimen Quality

         Patient's Perspective on Biospecimen Quality

         Incorporating Biospecimen Science Into Research and Clinical 
Practice

 

Key presenters to address the significant impact of biospecimen 
variability in cancer research and recent advances in biospecimen=20
science include:

                     Patrick O. Brown, M.D., Ph.D., Stanford University 
School of Medicine

                     Carolyn C. Compton, M.D., Ph.D., OBBR, NCI

                     Angelo deMarzo, M.D., Ph.D., Johns Hopkins University

                     Theo deVos, Ph.D., Epigenomics, Inc. 

                     Steve Gutman, M.D., M.B.A., Food and Drug=20
Administration

                     Elizabeth Hammond, M.D., FCAP, University of=20
Utah/LDS Hospital Daniel Hayes, M.D., University of Michigan

                     Scott Jewell, Ph.D., Ohio State University

                     Paula Kim, Translating Research Across Communities

                     Lance Liotta, M.D, Ph.D., George Mason University

                     Chris Logothetis, M.D., M.D. Anderson Cancer Center

                     Scott D. Patterson, Ph.D., Amgen Inc.

                     David Ransohoff, M.D., University of North=20
Carolina at Chapel Hill

                     Gerry Thomas, Ph.D. Imperial College London,=20
United Kingdom

                     Paul Waring, Ph.D., Genentech, Inc.

                     and others

 

This interactive symposium is free and open to the public and is 
expected to be of particular value to research investigators, 
clinicians, government representatives, industry representatives, and=20
patient advocates. *For more information, to register, and to submit an 
abstract, please visit www.brnsymposium.com .*

* *

We apologize if you receive more than one copy of this notice. Please=20
share this notice with any interested colleagues. We look forward to=20
your participation. If you have any questions about the meeting or=20
registration, please contact Marlene Goldman at 
mgoldman@md.capconcorp.com or 301-468-6004 ext. 416.

 

 

Sincerely,

 

Helen M. Moore, Ph.D.

Biospecimen Research Network Program Manager

Office of Biorepositories and Biospecimen Research

Office of the Director

National Cancer Institute

31 Center Drive, 31/10A03

Bethesda, MD 20892-2590

Phone:  (301) 496-1550

Fax:  (301) 480-4814

E-mail:  moorehe@mail.nih.gov 

http://biospecimens.cancer.gov 

-- 

Posted by
Andrea Kelly, Ph.D.

Rose Li & Associates
Contractor to NCI, OBBR


 


_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet




<< Previous Message | Next Message >>